Speed as a Moat: Compressing Decades of Biotech into Days Feat. Revilico & GIANT BioSystems | Sunstone Stage Connects
Biotech has always been limited by time—years to discover new drugs, and days to determine the right treatment. But what if both timelines could be compressed?
This week at Sunstone Stage Connects, we feature two frontier startups building at the intersection of AI, bioengineering, and healthcare—each tackling a different layer of the biotech stack, united by one core advantage: speed.
🔬 Featured Startups
Led by Christopher Korban, Revilico is rethinking how new therapeutics are discovered. By combining AI, computational chemistry, and lab automation, the company is moving beyond brute-force screening toward an intelligent, scalable approach to drug discovery—turning chemistry into a searchable system and accelerating the path from molecule to medicine.
Founded by Ehsan Shirzaei Sani, GIANT BioSystems is building a faster, more precise platform for infectious disease diagnostics. Using microfluidics and bioengineering, the company aims to replace multi-day delays in antibiotic testing with rapid, actionable insights—enabling real-time clinical decisions when they matter most.
About Sunstone
Sunstone Stage Connects is a weekly gathering that brings together founders, investors, and the community to spark ideas, share insights, and build meaningful connections.
Join us on Fridays as we connect you with our vibrant community of founders, investors, and innovators!
Join the Sunstone Stage Connects community:
Disclaimer: This communication, the event, the presenters and all topics discussed herein and at the events discussed in this communication are for educational purposes only. No investment is being solicited and no investment advice is provided herein or will be provided at those events. For our registered investment adviser Sunstone Advisors, LLC, please visit www.sunstoneadvisor.com.
Questions? Email [email protected].